Scholarly Works

Does androgen-deprivation therapy for prostate...

Journal article

Does androgen-deprivation therapy for prostate cancer increase the risk for thromboembolic disease?

Abstract

Does androgen-deprivation therapy for prostate cancer increase the risk for thromboembolic disease?

Authors

Pinthus JH; Duivenvoorden WC

Journal

Canadian Urological Association Journal, Vol. 11, No. 1-2, pp. 39–40

Publisher

Canadian Urological Association Journal

Publication Date

February 1, 2017

DOI

10.5489/cuaj.4394

ISSN

1911-6470

Associated Experts

Jehonathan Pinthus

Professor, Faculty of Health Sciences

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3202 Clinical sciences 3211 Oncology and carcinogenesis

View published work (Non-McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback